marstacimab-hncq
marstacimab-hncq is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand name including HYMPAVZI. Available dosage form: injection, solution.
Drug Details
- Generic Name
- marstacimab-hncq
- Brand Names
- HYMPAVZI
- Application Number
- BLA761369
- Sponsor
- Pfizer Laboratories Div Pfizer Inc
- NDC Codes
- 3
- Dosage Forms
- INJECTION, SOLUTION
- Routes
- SUBCUTANEOUS
- Active Ingredients
- MARSTACIMAB
Indications and Usage
1 INDICATIONS AND USAGE HYMPAVZI is indicated for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and pediatric patients 6 years of age and older with: • hemophilia A (congenital factor VIII deficiency) with or without factor VIII inhibitors, or • hemophilia B (congenital factor IX deficiency) with or without factor IX inhibitors. HYMPAVZI is a tissue factor pathway inhibitor (TFPI) antagonist indicated for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and pediatric patients 6 years of age and older with: • hemophilia A (congenital factor VIII deficiency) with or without factor VIII inhibitors, or • hemophilia B (congenital factor IX deficiency) with or without factor IX inhibitors. ( 1 )